Decoding 6 Analyst Evaluations For Pacira BioSciences
Decoding 6 Analyst Evaluations For Pacira BioSciences
解讀6位分析師對pacira biosciences的評價
The standing of Pacira BioSciences...Across the recent three months, 6 analysts have shared their insights on Pacira BioSciences (NASDAQ:PCRX), expressing a variety of opinions spanning from bullish to bearish.
在最近三個月中，6位分析師對pacira biosciences（納斯達克：PCRX）分享了他們的見解，表達了從看好到看淡的多種意見。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $21.17, a high estimate of $39.00, and a low estimate of $15.00. Highlighting a 2.31% decrease, the current average has fallen from the previous average price target of $21.67.
分析師分析的12個月價格目標提供了見解，平均目標爲21.17美元，高估計爲39.00美元，低估計爲15.00美元。突顯出2.31%的下降，當前平均值較之前的平均價格目標21.67美元有所下跌。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
The standing of Pacira BioSciences...
對paci...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。